Please Wait
Applying Filters...
menu
    • menu
    Virupaksha-PSE
    News
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta

    30 Sep 2024

    // BSEINDIA

    Novo Slides 14% On Early Q4 Results Forecasting 2026 Sales Drop

    04 Feb 2026

    // BIOSPACE

    FDA Rejects Az's Subcutaneous Version Of Lupus Drug Saphnelo

    04 Feb 2026

    // FIERCE PHARMA

    Data Compilation
    #PharmaFlow

    Read More

    Contact Supplier

    Website

    SCOPE Summit

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/fda-opoe
    Menu

    Oxygenta Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    INTERMEDIATES

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta
    Virupaksha Organics agreed to acquire 42.29% stake in Oxygenta

    30 Sep 2024

    // BSEINDIA

    https://www.bseindia.com/xml-data/corpfiling/AttachHis/1C45CF51-65B3-4DE7-B64C-CE5E996BBAD7-191527.pdf

    BSEINDIA
    30 Sep 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.